Article
TNF-α suppresses drug resistance via NF-κB/PXR pathway in non-small cell lung cancer
2021-01-20
Abstract excerpt
<h4>Background: </h4> Reduced sensitivity to chemotherapeutic agents caused by multidrug resistance is the main obstacle in the treatment of non-small cell lung cancer (NSCLC). Activated NF-κB/PXR pathway stimulated by procytokine TNF-α is implicated in the formation of multidrug resistance phenotype. However, the underlying mechanisms are obscure, and results concluded in various tumors are conflicted. Herein, we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 52df61cd-ec26-5fc8-b97f-6003989e625e
- DOI
- 10.21203/rs.3.rs-148624/v1
